Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma ; volume:24 ; number:1 ; day:6 ; month:11 ; year:2024 ; pages:1-12 ; date:12.2024
BMC cancer ; 24, Heft 1 (6.11.2024), 1-12, 12.2024
- Creator
-
Tian, Panpan
Tian, Xinyu
Gao, Lifen
Ma, Chunhong
Liang, Xiaohong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-13136-2
- URN
-
urn:nbn:de:101:1-2501242108251.165927015780
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tian, Panpan
- Tian, Xinyu
- Gao, Lifen
- Ma, Chunhong
- Liang, Xiaohong
- SpringerLink (Online service)
Other Objects (12)
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system